Regulus Therapeutics
RGLS
#8768
Rank
$96.23 M
Marketcap
$1.47
Share price
-0.68%
Change (1 day)
11.36%
Change (1 year)

Regulus Therapeutics (RGLS) Fails to deliver data

Key failure to deliver metrics for Regulus Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regulus Therapeutics (RGLS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regulus Therapeutics (RGLS) - since 2022

Volume in USD (price x number of shares), data since 2022

Regulus Therapeutics (RGLS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$5.86 M3760.49%
2023$0.15 M-85.22%
2022$1.02 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
$25.51 M$53.86 M๐Ÿ‡ฌ๐Ÿ‡ง UK
$9.72 M$72.48 M๐Ÿ‡ซ๐Ÿ‡ท France
$8.32 M$67.37 M๐Ÿ‡บ๐Ÿ‡ธ USA
$24.35 M$0.15 B๐Ÿ‡ฌ๐Ÿ‡ง UK
$5.12 M$37.97 M๐Ÿ‡บ๐Ÿ‡ธ USA
$1.94 M$2.52 M๐Ÿ‡บ๐Ÿ‡ธ USA
$35.64 M$0.34 B๐Ÿ‡บ๐Ÿ‡ธ USA